Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-04-02
2010-06-08
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S236000
Reexamination Certificate
active
07732463
ABSTRACT:
The invention provides compounds represented by the general formula (I) wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
REFERENCES:
patent: 3803143 (1974-04-01), Tanaka et al.
patent: 4018830 (1977-04-01), Christy
patent: 4055665 (1977-10-01), Christy
patent: 4056632 (1977-11-01), Mehta et al.
patent: 4066654 (1978-01-01), Adelstein et al.
patent: 4198417 (1980-04-01), Ong et al.
patent: 4198419 (1980-04-01), Ong et al.
patent: 4241071 (1980-12-01), Martin et al.
patent: 5095039 (1992-03-01), Mehta et al.
patent: 6410736 (2002-06-01), Howard, Jr. et al.
patent: 6436938 (2002-08-01), Howard, Jr.
patent: 6596741 (2003-07-01), Howard et al.
patent: 6677378 (2004-01-01), Howard, Jr. et al.
patent: 6699864 (2004-03-01), Ruhland et al.
patent: 7138407 (2006-11-01), Ruhland et al.
patent: 7144884 (2006-12-01), Ruhland et al.
patent: 7148238 (2006-12-01), Ruhland et al.
patent: 0 273 199 (1988-07-01), None
patent: 0 396 827 (1990-11-01), None
patent: 0 402 097 (1990-12-01), None
patent: 0 814 084 (1997-12-01), None
patent: 0 921 124 (1999-06-01), None
patent: 0 755 923 (2005-04-01), None
patent: WO 93/12080 (1993-06-01), None
patent: WO 97/17325 (1997-05-01), None
patent: WO 97/17352 (1997-05-01), None
patent: WO 98/08817 (1998-03-01), None
patent: WO 99/17777 (1999-04-01), None
patent: WO 00/50380 (2000-08-01), None
patent: WO-00/59878 (2000-10-01), None
patent: WO-00/59878 (2000-10-01), None
patent: WO 00/66537 (2000-11-01), None
patent: WO-01/10842 (2001-02-01), None
patent: WO-01/10842 (2001-02-01), None
patent: WO 01/27068 (2001-04-01), None
patent: WO 01/49678 (2001-07-01), None
patent: WO 01/49681 (2001-07-01), None
patent: WO-02/062766 (2002-08-01), None
patent: WO-02/062766 (2002-08-01), None
patent: WO 02/098857 (2002-12-01), None
patent: WO 03/029232 (2003-04-01), None
patent: WO 03/055873 (2003-07-01), None
patent: WO-2004/085385 (2004-10-01), None
patent: WO-2004/085385 (2004-10-01), None
patent: WO 2004/087155 (2004-10-01), None
patent: WO 2004/087662 (2004-10-01), None
patent: WO-2005/000309 (2005-01-01), None
patent: WO-2005/000309 (2005-01-01), None
Ong. et al. “Phenylthiphenylpiperidines” CA 93:71569 (1980).
Pueschl et al. “Preparation of [(phenylsulfanyl)phenyl . . . ” CA 141:332062 (2004).
Ruhland et al. “Preparation of phenylpiperazines . . . ” CA 138:304306 (2003).
Axford, L. et al., “Bicyclo[2.2.1]heptanes as Novel Triple Re-uptake Inhibitors for the Treatment of Depression”, Bioorg. Med. Chem. Lett., 2003, 13:3277-3280.
Buckle, D.R. and Rockell, C.J.M., “A Versatile Two-Stage Synthesis of 2-Substituted Benzo [b]furans from (2-Methoxyphenyl)ethynes”. J. Chem. Soc. Perkin Trans. I, 1985: 2443-2446.
Clayden, J., “Regioselective Synthesis of Organolithiums by X-Li Exchange.” In Organolithiums: Selectivity for Synthesis. Tetrahedron Organic Chemistry Series. 2002, New York, Pergamon. 23: 111-147.
Dabrowski, M., et al. “Halogen-lithium exchange between substituted dihalobenzenes and butyllithium: application to the regioselective synthesis of functionalized bromobenzaldehydes.” Tetrahedron. 2005. 61:6590-6595.
Emond, P., et al., “Substituted Diphenyl Sulfides as Selective Serotonin Transporter Ligands: Synthesis and In Vitro Evaluation”, J. Med. Chem., 2002, 45(6):1253-1258.
Hawkins, D.G., et al., “Competitive Cyclisation of Singlet and Triplet Nitrenes. Part 7. Reaction Pathways of 2-Azidophenyl Benzothienyl Azides”, J. Chem. Soc., Perkin Trans. I, 1979, 3207-3210.
Hurd, C.D. and Hoffman, W.A. “Directed Ring Closure in the Synthesis of Chromans and Coumarans from ortho-Allylphenols”. J. Am. Chem. Soc. 1940. 5:212-222.
Jackson, A., et al., “Electrophilic Substitution in Indoles Part 16. The Formation of lndolobenzothiazines and lndolobenzothiazepines by Intramolecular Cyclisation of (o-Nitrophenylthio)indoles”, J. Chem. Res. Miniprint 9, 1988, 2017-2063.
Jilek, J., et al., “Potential Antidepressants: 2-(Methoxy- and Hydroxy-Phenylthio)Benzylamines as Selective Inhibitors of 5-Hydroxytryptamine Re-uptake in the Brain”, Collect. Czech. Chem. Commun., 1989, 54:3294-3338.
Klint, T. and Weikop, P. “Monoamine transporters as continuing targets for drug discovery in depression”. Drug Discovery Today: Therapeutic Strategies. 2004. 1(1):111-116.
Kunz, K., et al. “Renaissance of Ullmann and Goldberg Reactions—Progress in Copper Catalyzed C-N-, C-O- and C-S-Coupling”. Synlett. 2003, 15: 2428-2439.
Mar., J. Advanced Organic Chemistry: Reaction Mechanisms, and Structure. 3rd ed. 1985. New York, John Wiley & Sons. pp. 342-343; 589-590; 684-685.
Millan, M.J. “The neurobiology and control of anxious states”. Progress in Neurobiology. 2003. 70:83-244.
Oya, S., et al., “A New Single-Photon Emission Computed Tomography Imaging Agent for Serotonin Transporters: [123I]IDAM, 5-lodo-2-((2-((dimethylamino)methyl)-phenyl)thio)benzyl Alcohol”, J. Med. Chem. 1999, 42(3):333-335.
Oya, S., et al., “New PET Imaging Agent for the Serotonin Transporter: [1 8 F]ACF (2-[(2-Amino-4-chloro-5-fluorophenyl)thio]-N,N-dimethyl-benzenmethanamine)”, J. Med. Chem. 2002, 45 (21):4716-4723.
Parham, W.E. and Jones, L.D. “Elaboration of Bromoarylnitriles”. J. Org. Chem. 1976. 41(7):1187-1191.
Ragno, R., et al., “Docking and 3-D QSAR Studies on Indolyl Aryl Sulfones. Binding Mode Exploration at the HIV-1 Reverse Transcriptase Non-Nucleoside Binding Site and Design of Highly Active N-(2-Hydroxyethyl) carboxamide and N-(2-hydroxyethyl)carbohydrazide Derivatives”, J. Med. Chem., 2005, 48(1):213-223.
Sakamuri, S., et al. “Pharmacophore-Based Discovery, Synthesis, and Biological Evaluation of 4-Phenyl-1-arylalkyl Piperidines as Dopamine Transporter Inhibitors”. Bioorg. Med. Chem. Lett. 2001. 11:495-500.
Sato, T., et al. “Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics”. Naunyn-Schmiedeberg's Arch Pharmacol. 2000. 361:214-220.
Siemsen, P., et al. “Acetylenic Coupling: A Powerful Tool in Molecular Construction”. Angew. Chem. Int. Ed. 2000. 39:2632-2657.
Silverman, R.B. The Organic Chemistry of Drug Design and Drug Action. 1992. San Diego. Academic Press. p. 19.
Silvestri, R., et al., “Novel Indolyl Aryl Sulfones Active Against HIV-1 Carrying NNRTI Resistance Mutations: Synthesis and SAR Studies”, J. Med. Chem. 2003, 46(12):2482-2493.
Sindelar, K., et al., “Potential Antidepressants and Inhibitors of 5-Hydroxy-Tryptamine and Noradrenaline Re-uptake in the Brain: N,N-Dimethyl-(Arylthio)Thenylamines and N,N-Dimethyl-2-(Thienylthio)Benzylamines”, Collect. Czech. Chem. Commun. 1991, 56:449-458.
Tamiz, A.P., et al. “Further SAR Studies of Piperidine-Based Analogues of Cocaine. 2. Potent Dopamine and Serotonin Reuptake Inhibitors”. J. Med. Chem. 2000. 43(6):1215-1222.
Wang, S., et al. “Discovery of a Novel Dopamine Transporter Inhibitor, 4-Hydroxy-1-methyl 4 (4-methylphenyI)-3-piperidyl 4-Methylphenyl Ketone, as a Potential Cocaine Antagonist through 3D-Database Pharmacophore Searching. Molecular Modeling, Structure—Activity Relationships, and Behavioral Pharmacological Studies”. J. Med. Chem. 2000. 43(3): 351-360.
Martin et al., “Synthesis of Spiro[isobenzofuran-1(3H),4′-piperidines] as Potential Central Nervous System Agents. 5. Conformationally Mobile Analogues Derived by Furan Ring Opening,”Journal of Medicinal Chemistry, vol. 22, No. 11, pp. 1347-1354, 1979.
Bang-Andersen Benny
Jorgensen Morten
Puschl Ask
Ruhland Thomas
Stensbol Tine B.
Buck Margaret M.
Chang Celia
H. Lundbeck A/S
Kalinchak Stephen G.
LandOfFree
4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4198109